Last reviewed · How we verify
Taking drug Tamsulosin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Taking drug Tamsulosin (Taking drug Tamsulosin) — Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Taking drug Tamsulosin TARGET | Taking drug Tamsulosin | Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Taking drug Tamsulosin CI watch — RSS
- Taking drug Tamsulosin CI watch — Atom
- Taking drug Tamsulosin CI watch — JSON
- Taking drug Tamsulosin alone — RSS
Cite this brief
Drug Landscape (2026). Taking drug Tamsulosin — Competitive Intelligence Brief. https://druglandscape.com/ci/taking-drug-tamsulosin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab